Newsletter | October 1, 2024

10.01.24 -- AI Is A Tool — Not A Replacement — For Human Innovation In Drug Discovery

FEATURED EDITORIAL

AI Is A Tool — Not A Replacement — For Human Innovation In Drug Discovery

This attorney provides practical advice. Can artificial intelligence (AI) make drug discovery easier? Yes! Will we lose the human component essential to the innovation culture? No.

INDUSTRY INSIGHTS

Nanoformed API: A Superior Alternative To Solid Dispersions

Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.

Spray-Dried Dispersions Enable Local Delivery For Lung Cancer

Learning more about spray drying as well as two case studies detailing its success serves as a critical tool in developing innovative and effective lung cancer therapies.

Powering Drug Development With Advanced AI Retrosynthetic Analysis Tools

Review advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.

Building A Broad Oncology Portfolio With SOTIO CEO Dr. Radek Špíšek

Establishing an organization that can manage a diverse development pipeline for oncology therapies requires an equally diverse wealth of expertise.

Predictive Data Modeling Using AI/ML

Learn how an innovative clone-selection technology can improve your cell line development.

MOST POPULAR NEWS

FDA Approves New Drug To Treat Niemann-Pick Disease, Type C

ReSync Bio Launches To Automate Data And Operations In Drug Discovery

Orion & Aitia Enter AI-Driven Drug Discovery & Drug Simulation Collaboration In Oncology

XtalPi Launches Computational Chemistry Software For Drug Discovery: XMolGen & XFEP

FDA Accepts LEO Pharma's Filing Of Delgocitinib Cream NDA For The Treatment Of CHE

KSQ Therapeutics Announces FDA Clearance Of IND Application For KSQ-004EX

New AI Tool Efficiently Deconvolutes Compound-Protein Interactions

Generate:Biomedicines Announces Multi-Target Collaboration With Novartis

AI Trained On Evolution's Playbook Develops Proteins That Spur Drug & Scientific Discovery

Lundbeck & Iambic Therapeutics Announce Strategic Partnership To Leverage AI For Drug Discovery

Axcelead Drug Discovery Partners Enters Into Master Service Agreement With Acadia Pharmaceuticals

SOLUTIONS

High Energy Chemistry

MabSelect VH3 Protein A Affinity Resin